The risk of developing uterine sarcoma after tamoxifen use

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 352-356

  Lavie, O ^a   Barnett Griness, O ^b   Narod, S A ^c   Rennert, G ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Endometrial cancer; Tamoxifen; Uterine sarcoma

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; ISRAEL; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERUS SARCOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SARCOMA; TAMOXIFEN; UTERINE NEOPLASMS;

EID: 40549132583     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01025.x     Document Type: Article

References (22)

1. Fisher B, Dignam J, Wolmark N et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 1999 353 : 1993 2000.
2. Fisher B, Constantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study l. J Natl Cancer Inst 1998 90 : 1371 88.
3. Early Breast Cancer Trial Collaborative Group (EBCTCG). Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998 351 : 1451 68.
4. Bissett D, Davis JA, George WD. Gynaecological monitoring during tamoxifen therapy. Lancet 1994 344 : 1244 5.
5. Wysowski DK, Honing SF, Beitz J. Uterine sarcoma associated with tamoxifen use. N Engl J Med 2002 346 : 1832 3.
6. Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 1998 45 : 608 12.
7. Bergman L, Beelen ML, Gallee MP et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer: comprehensive Cancer Centers' ALERT group-assessment of liver and endometrial cancer risk following tamoxifen. Lancet 2000 356 : 881 7.
8. Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer risk of endometrial cancer: a case control study. J Natl Cancer Inst 2005 97 : 375 84.
9. Silva EG, Tornos CS, Follen-Mitchell M. Malignant neoplasm of the uterine corpus in patients treated for breast carcinoma: the effect of tamoxifen. Int J Pathology 1994 13 : 248 58.
10. Clark MR. Uterine malignant mixed mullerian tumor in a patient on long-term tamoxifen therapy for breast cancer. Gynecol Oncol 1993 51 : 411 5.
11. Hubalek M, Ramoni A, Holzner E, Marth C. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer. Gynecol Oncol 2004 95 : 264 6.
12. Yildrim Y, Inal MM, Sanci M et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases. Int J Gynecol Cancer 2005 15 : 1239 42.
13. Arenas M, Roviroso A, Hernandez V et al. Uterine sarcoma in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer 2006 16 : 861 5.
14. Wolf DM, Fuqua SW. Mechanisms of action of antiestrogens. Cancer Treat Rev 1995 21 : 247 71.
15. Pink JJ, Jordan VC. Models of estrogen receptor regulation by estrogen and antiestrogens in breast cancer cell lines. Cancer Res 1996 56 : 2321 30.
16. Fornander T, Rutqvist LE, Cedermark B et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989 1 : 117 20.
17. Murphy GP, Lawrence W, Lenhard RE. Gynecologic sarcomas. In : American Cancer Society Textbook of Clinical Oncology, 2 edn. Atlanta : GA American Cancer Society, 1995 : 573 4.
18. Wickerham D, Fisher B, Wolmark N et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002 20 : 2758 60.
19. Bernstein LD, Deapen D, Cerhan JR et al Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 1999 91 : 1654 62.
20. Butta A, MacLennan K, Flanders KC et al. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen. Cancer Res 1992 52 : 4261 4.
21. Zelmanowicz A, Hildesheim A, Sherman ME et al. Evidence for a common ethiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998 69 : 253 7.
22. Altaras MM, Jaffe R, Cohen I et al. Role of prolonged excessive estrogen stimulation in the pathogenesis of endometrial sarcomas: two cases and a review of the literature. Gynecol Oncol 1990 38 : 273 7.